Results 341 to 350 of about 343,340 (395)

FIGURE 1 from Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy

Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Gabriele Zoppoli, Luc Dirix, Kevin Punie, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne Vincent‐Salomon, Denis Larsimont, Caroline Duhem, Patrice Viens, François Bertucci, Elia Biganzoli, Peter Vermeulen, Giuseppe Floris, Christine Desmedt   +29 more
openalex   +1 more source

AI-detected tumor-infiltrating lymphocytes for predicting outcomes in anti-PD1 based treated melanoma

Schuiveling M, van Duin IA, Maat Lt, van der Weerd JC, Verheijden RJ, van den Berkmortel F, Blank CU, Breimer GE, Burgers FH, Boers-Sonderen M, van den Eertwegh AJM, de Groot JWB, Haanen JB, Hospers GA, Kapiteijn E, Piersma D, Vreugdenhil G, Westgeest H, Schrader AM, Pluim J, van Diest PJ, Veta M, Suijkerbuijk KP, Blokx W.   +23 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor-infiltrating lymphocytes: A new hope

Cancer Cell
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2.
Amod A, Sarnaik, Patrick, Hwu, James J, Mulé, Shari, Pilon-Thomas   +3 more
openaire   +3 more sources

Tumor-Infiltrating Lymphocytes

The Cancer Journal, 2015
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in combination with lymphodepletion and high-dose interleukin 2 has shown reproducible objective response rates of approximately 50% in patients with highly advanced, refractory metastatic melanoma.
Michal J, Besser, Ronnie, Shapira-Frommer, Jacob, Schachter   +2 more
openaire   +3 more sources

Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.

Annals of Surgery, 2020
OBJECTIVE To determine whether prognostic nutritional index (PNI) affects clinical outcome through local immunity in esophageal cancers. BACKGROUND PNI is an indicator of nutritional status and systemic immune competence, and has attracted attention as
K. Okadome, Y. Baba, T. Yagi, Y. Kiyozumi, T. Ishimoto, M. Iwatsuki, Y. Miyamoto, N. Yoshida, Masayuki Watanabe, H. Baba   +9 more
semanticscholar   +1 more source

Tumor microenvironment and lymphocyte infiltration

Cancer Immunology, Immunotherapy, 2012
There is ample evidence that the presence of tumor-infiltrating T lymphocytes is associated with a favorable prognostic in patients. These observations suggest that a limiting step to immune resistance and immunotherapy could be the capacity of tumor-specific T cells to reach tumor bed.
Rahir, Gwendoline, Moser, Muriel
openaire   +2 more sources

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Journal of the American Medical Association (JAMA)
Importance The association of tumor-infiltrating lymphocyte (TIL) abundance in breast cancer tissue with cancer recurrence and death in patients with early-stage triple-negative breast cancer (TNBC) who are not treated with adjuvant or neoadjuvant ...
R. Leon-Ferre, S. Jonas, R. Salgado, S. Loi, V. D. de Jong, Jodi M. Carter, Torsten O. Nielsen, Samuel Leung, N. Riaz, Stephen K. L. Chia, Gerome Jules-Clement, G. Curigliano, C. Criscitiello, Vincent Cockenpot, M. Lambertini, Vera J Suman, B. Linderholm, John W. M. Martens, C. V. van Deurzen, A. M. Timmermans, T. Shimoi, S. Yazaki, Masayuki Yoshida, Sung-Bae Kim, Hee Jin Lee, M. Dieci, Guillaume Bataillon, A. Vincent‐Salomon, Fabrice André, M. Kok, Sabine C. Linn, M. Goetz, S. Michiels   +32 more
semanticscholar   +1 more source

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy

The Cancer Journal, 2015
Autologous adoptive T-cell therapies have made tremendous strides over the last few years with excitement currently being generated by technologies that can reprogram T-cell specificities toward any desired antigen including chimeric antigen receptors and recombinant T-cell receptors.
openaire   +2 more sources